Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Pauls currently holds 13,578 shares of Strongbridge Biopharma plc (SBBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Pauls has been a net seller of SBBP stock. They have purchased $240.1K and sold $412.1K worth of shares.
Matthew Pauls's most recent insider trade was on Oct 2, 2026, when they sold 786 shares at $21.00 per share.
Matthew Pauls serves as Executive at Strongbridge Biopharma plc (SBBP). They have executed 38 insider transactions totaling $652.3K over their tenure at the company.
Matthew Pauls holds the position of Executive at Strongbridge Biopharma plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Matthew Pauls has shown a selling trading pattern, with $240.1K in total purchases and $412.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew Pauls was on Dec 14, 2025, when they sold $1.4M worth of SVRA shares. This transaction involved 195,705 shares at $6.92 per share.
Matthew Pauls currently owns 13,578 shares of Strongbridge Biopharma plc (SBBP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Pauls's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Pauls has 38 Form 4 filings on record as an insider at Strongbridge Biopharma plc.
Set alerts for Matthew Pauls and 40,000+ other insiders.